透過您的圖書館登入
IP:18.118.146.60
  • 期刊

Effects of Alendronate and Alfacalcidol on the Femoral Bone Mass and Bone Strength in Orchidectomized Rats

並列摘要


The purpose of the present study was to compare the effects of alendronate (ALN) and alfacalcidol (ALF) on the femoral bone mass and bone strength in orchidectomized rats and to clarify the skeletal benefits of combined administration of ALN and ALF. Fifty male Sprague-Dawley rats, 3 months of age, were randomized by the stratified weight method into five groups: the age-matched control (CON), orchidectomy (ORX), ORX + ALN (2.5 μg/kg, s.c., 5 times a week), ORX + ALF (0.1 μg/kg, p. o., 5 times a week), and ORX + ALN + ALF groups. After 12 weeks of feeding, the femoral distal metaphysis and mid-diaphysis were processed for peripheral quantitative tomographic analysis and biomechanical testing. In the femoral distal metaphysis, ALN prevented the ORX-induced reduction in the trabecular volumetric bone mineral density (vBMD) and breaking energy, and ALF prevented the ORX-induced reduction in the trabecular vBMD and increased the breaking energy to values above those observed in the CON group. Both ALN and ALF increased the maximum load to values above those observed in the ORX group. The improvements in parameters described above were more pronounced when ALN and ALF were administered in combination. In the femoral mid-diaphysis, on the other hand, ALN did not significantly affect the cortical bone parameters, whereas ALF increased the cortical area and maximum load to values above those observed in the ORX group. Furthermore, no apparent benefit of combined administration of ALN and ALF was observed. These findings suggest differential effects of ALN and ALF on femoral bone mass and the beneficial effects of combined administration of ALN and ALF on the trabecular bone of the femur in ORX rats.

並列關鍵字

orchidectomy BMD alendronate alfacalcidol rat

參考文獻


Behre, H.M.,Kliesch, S.,Leifke, E.,Link, T.M.,Nieschlag, E.(1997).Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.J. Clin. Endocrinol. Metab..82,2386-2390.
Bertelloni, S.,Baroncelli, G.I.,Battini, R.,Perri, G.,Saggese, G.(1995).Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty.J. Bone Miner. Res..10,1488-1495.
Broulik, P.D.,Rosenkrancova, J.,Ruzicka, P.,Sedlacek, R.(2005).Effect of alendronate administration on bone mineral density and bone strength in castrated rats.Horm. Metab. Res..37,414-418.
Chappard, D.,Petitjean, M.,Alexandre, C.,Vico, L.,Minaire, P.,Riffat, G.(1991).Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts.J. Bone Miner. Res..6,673-680.
Erben, R.G.,Eberle, J.,Stahr, K.,Goldberg, M.(2000).Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study.J. Bone Miner. Res..15,1085-1098.

被引用紀錄


Shih, R. (2011). 評估BMP2對治療股骨頭壞死之成效 [master's thesis, Taipei Medical University]. Airiti Library. https://doi.org/10.6831/TMU.2011.00091

延伸閱讀